Knight Therapeutics Inc. (GUD.TO)
| Previous Close | 5.79 |
| Open | 5.80 |
| Bid | 5.75 x 0 |
| Ask | 5.78 x 0 |
| Day's Range | 5.71 - 5.80 |
| 52 Week Range | 4.35 - 5.95 |
| Volume | |
| Avg. Volume | 73,433 |
| Market Cap | 583.751M |
| Beta (5Y Monthly) | 0.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.16 |
| Earnings Date | May 09, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.73 |
Simply Wall St.Knight Therapeutics (TSE:GUD) shareholders have endured a 21% loss from investing in the stock five years ago
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...
The Motley FoolTSX Healthcare in April 2024: The Best Stocks to Buy Right Now
TSX’s healthcare sector is not as popular as the heavyweight sectors, but it has three of the best stocks you can buy in April. The post TSX Healthcare in April 2024: The Best Stocks to Buy Right Now appeared first on The Motley Fool Canada.
GlobeNewswireKnight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024, at 10:30 a.m. ET at the Metro Toronto Convention Centre in Toronto. A copy of the presentation will be available at www.knighttx.com. About
